Following successful community gynaecology pilots in Rushcliffe and Nottingham West, Greater Nottingham Clinical Commissioning Partnership seeks to procure a community gynaecology service for patients in Nottingham City, Nottingham North and East, Nottingham West and Rushcliffe Clinical Commissioning Groups.

The commissioners are seeking to procure a service which delivers a range of gynaecologic interventions, providing an alternative community setting for first and follow up appointments currently seen in secondary care. The proposed service will improve access and service user experience of services, and promote self-care and improve the health and wellbeing of residents.

The Contract value is anticipated to be 589 742 GBP pa. The contract will be let for circa 33 months with a possible extension of any period up to a further 24 months. Services are planned to commence from 1.7.2019.

Greater Nottingham Clinical Commissioning Partnership is seeking to procure a community gynaecology service for patients in Nottingham City, Nottingham North and East, Nottingham West and Rushcliffe Clinical Commissioning Groups.

The overall aim of this proposed procurement is to reduce secondary care activity, clinical variation in referral behaviour and improve patient experience. The requirement will be a consultant led service that provides clinical triage of all gynaecology routine referrals.

The expectation is that all patients with a routine gynaecology referral will be referred to the community gynaecology service for triage/treatment (and advice and guidance if applicable). Patients will only be referred to secondary care where there is a definite need for hospital based specialist services. The community gynaecology service will provide a single point of access for service users and health professionals and provide a multi-skilled approach to assessment, diagnosis and treatment to the management of gynaecological conditions. The conditions that the community gynaecology service will see will include, but not be limited to:

— menstrual disorders (excluding post-menopausal bleeding),

— fibroids,

— cervical polyps,

— polycystic ovarian syndrome,

— pelvic pain,

— ovarian cysts,

— prolapse,

— sterilisation requests,

— vulval disorders,

— prolapse/pessary changes,

— menopause problems/severe premenstrual syndrome,

— dyspareunia.

The contract value is anticipated to be circa 589 742 GBP pa and the contract will be let for circa 33 months with a possible extension of any period (or periods) up to a further 24 months, as defined at the discretion of the commissioner. Services are planned to commence from 1.7.2019.

This procurement is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.